{
    "root": "52b9369d-2360-4c63-b942-b154c3993e9f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nexterone",
    "value": "20250221",
    "ingredients": [
        {
            "name": "AMIODARONE HYDROCHLORIDE",
            "code": "976728SY6Z"
        },
        {
            "name": "BETADEX SULFOBUTYL ETHER SODIUM",
            "code": "2PP9364507"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "ANHYDROUS DEXTROSE",
            "code": "5SL0G7R0OK"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "NEXTERONE Premixed Injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy.",
    "contraindications": "• The recommended starting dosing regimen is: (2) o Initial Load:  150 mg in 100 mL  infused over 10 minutes o Followed by:  1 mg/min for 6 hours o Followed by:  0.5 mg/min thereafter • For breakthrough episodes of VF or hemodynamically unstable VT, repeat the Initial Load (2)",
    "warningsAndPrecautions": "NEXTERONE (amiodarone HCl) Premixed Injection is supplied as a ready-to-use, sterile, nonpyrogenic, iso-osmotic solution in 100 mL and 200 mL single-dose GALAXY containers packaged in individual cartons as follows:\n                  \n                     \n                     \n                     \n                        \n                           \n                              150 mg/100 mL\n                           \n                           \n                              NDC 43066 – 150 – 10\n                           \n                        \n                        \n                           \n                              360 mg/200 mL\n                           \n                           \n                              NDC 43066 – 360 – 20\n                           \n                        \n                     \n                  \n                  Do not add supplementary medication to NEXTERONE Premixed Injection.\n                  Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F).  See USP Controlled Room Temperature.\n                  Protect from light and excessive heat. Protect from freezing.\n                  Use carton to protect contents from light until used.",
    "adverseReactions": "NEXTERONE Premixed Injection is contraindicated in patients with:\n                  \n                     \n                        •Known hypersensitivity to any of the components of NEXTERONE Premixed Injection, including iodine [\n                           see Warnings and Precautions (5.9)\n                        ]. \n                     \n                        •Cardiogenic shock.\n                     \n                        •Marked sinus bradycardia.\n                     \n                        •Second- or third-degree atrioventricular (AV) block unless a functioning pacemaker is available."
}